You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
12 April 2024
Formycon AG publishes preliminary figures for the 2023 financial year and guidance for the 2024 financial year
29 January 2024
Formycon resolves on cash capital increase of EUR 82.84 million – all new shares were subscribed by Gedeon Richter as new strategic investor
2 February 2023
Formycon AG announces result of private placement and sets placement price for the new shares from the capital increase
1 February 2023
Formycon AG upsizes capital increase from authorized capital following strong demand
Formycon AG announces global license agreement with Fresenius Kabi for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab)
Formycon AG plans capital increase of approx. 5% of the share capital by way of an accelerated bookbuilding procedure to finance further growth